HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
1-Year Return
16.34%
This Quarter Return
-0.23%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.39B
AUM Growth
+$387M
(+13%)
Cap. Flow
+$394M
Cap. Flow
% of AUM
11.65%
Top 10 Holdings %
Top 10 Hldgs %
32.13%
Holding
245
New
13
Increased
127
Reduced
99
Closed
4
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
+$72.4M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$54.5M |
| 3 |
Tesla
TSLA
|
+$39.8M |
| 4 |
NVIDIA
NVDA
|
+$30.3M |
| 5 |
Palantir
PLTR
|
+$25.3M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$24.5M |
| 2 |
AbbVie
ABBV
|
+$7.44M |
| 3 |
Amgen
AMGN
|
+$6.52M |
| 4 |
Telus
TU
|
+$5.65M |
| 5 |
Boston Scientific
BSX
|
+$3.29M |
Sector Composition
| 1 | Healthcare | 34.85% |
| 2 | Technology | 22.06% |
| 3 | Financials | 6.11% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Communication Services | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$49.6B
| $331M | 9.78% |
3,638,683
+599,149
| +20% | +$54.5M |
|
2
iShares 7-10 Year Treasury Bond ETF
IEF
$36.1B
| $138M | 4.07% |
1,443,149
+157,184
| +12% | +$15M |
|
3
Eli Lilly
LLY
$677B
| $104M | 3.08% |
126,155
+3,263
| +3% | +$2.69M |
|
|
4
NVIDIA
NVDA
$4.33T
| $104M | 3.06% |
954,984
+279,296
| +41% | +$30.3M |
|
5
UnitedHealth
UNH
$319B
| $78.9M | 2.33% |
150,694
+14,061
| +10% | +$7.36M |
|
6
Microsoft
MSFT
$3.79T
| $77M | 2.28% |
205,207
+47,292
| +30% | +$17.8M |
|
|
7
Strategy Inc Common Stock Class A
MSTR
$94B
| $72.4M | 2.14% |
+251,295
| New | +$72.4M |
|
8
Elevance Health
ELV
$70.2B
| $62.1M | 1.83% |
142,721
+1,573
| +1% | +$684K |
|
9
AstraZeneca
AZN
$247B
| $60.6M | 1.79% |
823,961
+9,883
| +1% | +$726K |
|
10
Bristol-Myers Squibb
BMY
$94B
| $60.1M | 1.78% |
985,650
+53,005
| +6% | +$3.23M |
|
11
Abbott
ABT
$233B
| $58.2M | 1.72% |
439,005
-14,773
| -3% | -$1.96M |
|
|
12
Amgen
AMGN
$149B
| $57.5M | 1.7% |
184,560
-20,931
| -10% | -$6.52M |
|
|
13
Johnson & Johnson
JNJ
$429B
| $57.2M | 1.69% |
344,702
-147,763
| -30% | -$24.5M |
|
14
Merck
MRK
$207B
| $56.4M | 1.67% |
628,424
+86,268
| +16% | +$7.74M |
|
15
Novartis
NVS
$240B
| $56.1M | 1.66% |
503,638
-26,702
| -5% | -$2.98M |
|
|
16
AbbVie
ABBV
$386B
| $56M | 1.65% |
267,258
-35,530
| -12% | -$7.44M |
|
17
Zoetis
ZTS
$65.7B
| $55.3M | 1.64% |
336,138
+20,547
| +7% | +$3.38M |
|
18
Medtronic
MDT
$121B
| $55.1M | 1.63% |
613,690
-31,355
| -5% | -$2.82M |
|
|
19
Boston Scientific
BSX
$152B
| $54.8M | 1.62% |
543,368
-32,607
| -6% | -$3.29M |
|
20
Regeneron Pharmaceuticals
REGN
$59.4B
| $52.6M | 1.55% |
82,924
+11,555
| +16% | +$7.33M |
|
21
Stryker
SYK
$147B
| $52.6M | 1.55% |
141,281
-1,365
| -1% | -$508K |
|
22
Danaher
DHR
$136B
| $50.9M | 1.5% |
248,049
+22,200
| +10% | +$4.55M |
|
23
Thermo Fisher Scientific
TMO
$181B
| $49.6M | 1.47% |
99,740
+414
| +0.4% | +$206K |
|
24
Vanguard Long-Term Treasury ETF
VGLT
$10.2B
| $48.1M | 1.42% |
834,205
+4,578
| +0.6% | +$264K |
|
25
Intuitive Surgical
ISRG
$161B
| $48M | 1.42% |
96,823
-52
| -0.1% | -$25.8K |
|